Longevity Acquisition Corp - Units (1 Ord, 1 Rts & 1 War)

Longevity Acquisition Corp. engages in the acquisition of entities engaging in a share exchange, share reconstruction and amalgamation with, or in any other similar business combination with one or more businesses. The company was March 9, 2018 and is headquartered in Shanghai, China.

Longevity Acquisition Corp

LEEDS, England--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces the filing of a registration statement on Form F-4 (the “Registration Statement”) with the US Securities and Exchange Commission (SEC). The filing follows the announcement on October 22, 2020 of the proposed merger between 4D pharma and Longevity Acquisition Corporation (NASDAQ: LO

4D pharma plc Files SEC Forms in Process to Gain NASDAQ Listing Following Merger with Longevity, a Special Purpose Acquisition Company (SPAC)

SHANGHAI, Oct. 22, 2020 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company" or "LOAC"), a publicly-traded special purpose acquisition company (SPAC), announced that it has signed a definitive merger agreement with 4D pharma PLC (AIM: DDDD, "4D pharma" or "4D")....

News for Longevity Acquisition Corp - Units (1 Ord, 1 Rts & 1 War) Stock (LOACU)